ReviewTranslational lung cancer research2021

Combining radiotherapy with targeted therapies in non-small cell lung cancer: focus on anti-EGFR, anti-ALK and anti-angiogenic agents.

Anna Wrona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.